Health coaching app developer Noom, best known for its direct-to-consumer weight loss app, raises $58M Series E led by Sequoia, bringing total raised to $114.7M
Context & Ripple Effects
In May 2019 Noom's $58M Series E was a mid-stage bet on a direct-to-consumer app built around human coaching plus behavior change — Sequoia's lead took total raised to just $114.7M. Two years later the same company raised $540M at a reported $3.7B valuation, with Bloomberg citing $400M in 2020 sales, making this round the seedbed of one of the fastest climbs in consumer health.
The round also landed in what became a crowded lane: Found emerged with a $24M Series A plus seed before adding a $100M Series B at a $600M valuation, while UK rival Oviva and India's HealthifyMe each crossed the $100M total-raised mark. The reckoning came fast — by late 2022 Noom cut about 10% of staff, roughly 500 people, mostly from its coaching team.
First-order effects
- Sequoia's lead gives Noom the capital to scale its coaching-intensive subscription model at a moment when D2C weight loss is still pre-GLP-era competition for attention.
- Alfred Lin and Pat Grady take stewardship of the investment, putting a top consumer-franchise firm behind an unproven-in-public category.
Second-order effects
- Noom's growth trajectory helps pull a funding wave behind it — Found, Oviva, and HealthifyMe all raise large rounds within roughly two years, turning solo app builders into a capitalized competitive field.
- Rivals like Found differentiate with a telehealth component layered onto app-based weight loss, pressuring Noom's pure coaching-plus-behavior pitch.
Third-order effects
- Noom's 2022 cuts concentrated in the coaching team expose the structural weakness of a human-labor-heavy model: every new subscriber adds recurring coach cost, so margin pressure eventually lands exactly where the product's value sits.
- If the pattern holds, weight-care apps consolidate around whichever mix of software automation and clinical services can hold unit economics together — the category this round helped capitalize becomes a test of whether coached behavior change survives as a standalone business.
The trend: Consumer health apps are racing from behavior-change subscriptions into heavily capitalized, clinically adjacent platforms, where the cost of human coaching becomes the deciding structural constraint.